These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8773214)

  • 1. Intracerebral injection of phospholipase A2 inhibits dopamine-mediated behavior in rats: possible implications for schizophrenia.
    Brunner J; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 1995; 246(1):13-6. PubMed ID: 8773214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Accelerated breakdown of membrane phospholipids in schizophrenia--implications for the hypofrontality hypothesis].
    Gattaz WF; Brunner J; Schmitt A; Maras A
    Fortschr Neurol Psychiatr; 1994 Dec; 62(12):489-96. PubMed ID: 7835820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase A2 and the hypofrontality hypothesis of schizophrenia.
    Gattaz WF; Brunner J
    Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):109-13. PubMed ID: 8888132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricular injection of phospholipase A2 inhibits apomorphine-induced locomotion in rats.
    Brunner J; Gattaz WF
    Psychiatry Res; 1995 Sep; 58(2):165-9. PubMed ID: 8570769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet phospholipase A2 activity in schizophrenia.
    Gattaz WF; Schmitt A; Maras A
    Schizophr Res; 1995 Jul; 16(1):1-6. PubMed ID: 7547640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
    Chopin P; Colpaert FC; Marien M
    J Pharmacol Exp Ther; 1999 Feb; 288(2):798-804. PubMed ID: 9918591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML; Currie RW; Robertson HA
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible involvement of phospholipase A2 in the pathogenesis of schizophrenia].
    Gattaz WF; Nevalainen TJ; Kinnunen PK
    Fortschr Neurol Psychiatr; 1990 Apr; 58(4):148-53. PubMed ID: 2354835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of noradrenaline and dopamine in contraversive circling behaviour seen after unilateral electrolytic lesions of the locus coeruleus.
    Donaldson I; Dolphin A; Jenner P; Marsden CD; Pycock C
    Eur J Pharmacol; 1976 Oct; 39(2):179-91. PubMed ID: 976315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denervation-like postsynaptic supersensitivity to dopamine agonists induced by microinjection of colchicine into the substantia nigra pars compacta.
    Kamata K; Kameyama T; Okuyama S; Hashimoto S; Aihara H
    Brain Res; 1986 Mar; 367(1-2):1-7. PubMed ID: 3008917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum phospholipase A2 activity in schizophrenia: a replication study.
    Gattaz WF; Hübner CV; Nevalainen TJ; Thuren T; Kinnunen PK
    Biol Psychiatry; 1990 Sep; 28(6):495-501. PubMed ID: 2223919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotational behavior in dopamine nigrostriatal denervated rats: effects of a wide range of time intervals between apomorphine administrations.
    Casas M; Prat G; Robledo P; Jané F
    Pharmacol Biochem Behav; 1999 Mar; 62(3):481-5. PubMed ID: 10080240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic--GABA-ergic interaction in the nigrostriatal system.
    Koltai MZ; György L
    Acta Physiol Acad Sci Hung; 1981; 58(3):225-33. PubMed ID: 7348023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.
    Sañudo-Peña MC; Patrick SL; Patrick RL; Walker JM
    Neurosci Lett; 1996 Mar; 206(1):21-4. PubMed ID: 8848272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification by apomorphine of the circling behaviour in the rat due to unilateral intranigral injection of 1-methyl-4-phenylpyridine (MPP+).
    Lange KW
    J Toxicol Clin Exp; 1989; 9(1):21-5. PubMed ID: 2787400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.
    Aoi M; Date I; Tomita S; Ohmoto T
    Neurosci Res; 2000 Apr; 36(4):319-25. PubMed ID: 10771110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nigral dopaminergic mechanisms in drug-induced circling.
    Jackson EA; Kelly PH
    Brain Res Bull; 1983 Nov; 11(5):605-11. PubMed ID: 6607768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.